Curanex Pharmaceuticals Inc 8-K

What Happened Curanex Pharmaceuticals (CURX) filed a Form 8-K on March 6, 2026 disclosing changes in its officers/directors and attaching new employment agreements. The filing incorporates information under Item 5.02 relating to Dr. Liqin Xie and includes signed employment agreements for Jun Liu and Dr. Liqin Xie effective March 1, 2026.

Key Details

• Filing date: March 6, 2026 (Form 8-K).
• Employment agreements: Exhibit 10.1 — Jun Liu; Exhibit 10.2 — Dr. Liqin Xie; both effective March 1, 2026.
• Item 5.02: The report addresses a director/officer change involving Dr. Liqin Xie (information for Item 5.02 is incorporated by reference).
• The submission also included the Interactive XBRL cover page (Exhibit 104).

Why It Matters Changes to company officers or directors and the execution of employment agreements are material corporate-governance events investors track because they affect leadership, strategy execution, and potential compensation obligations. This 8-K does not include financial results; investors should watch for follow-up filings or press releases for titles, roles, compensation details, and any potential impact on operations or strategy.